Abstract
It is empirically known that anaplastic transformation can be recognized in relapsed lesions of differentiated carcinoma. In this CQ, risk factors for anaplastic transformation and its clinical behavior, standard treatment for such cases, and treatment results are discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ozaki O, Ito K, Mimura T et al (1999) Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: a histologic and immunohistochemical study. J Surg Oncol 70:45–48 (CaseR)
Kitamura Y, Shimizu K, Nagahama M et al (1999) Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 84:4043–4049 (RS)
Ozumi S, Takashima N, Bandai K et al (1996) (Text in Japanese) Ganno Rinsho 42:267–272 (RS)
Brabant G, Maenhaut C, Kohrle J et al (1991) Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 82:R7–R12 (Others)
Wiseman SM, Griffith OL, Deen S et al (2007) Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma. Arch Surg 142:717–727, discussion 727–729 (Others)
Ito Y, Higashiyama T, Hirokawa M et al (2008) Prognosis of patients with papillary carcinoma showing anaplastic transformation in regional lymph nodes that were curatively resected. Endocr J 55:985–989 (CaseR)
Shaha AR (2008) Airway management in anaplastic thyroid carcinoma. Laryngoscope 118:1195–1198 (RS)
Takano T, Ito Y, Hirokawa M (2007) BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas. Br J Cancer 96:1549–1553 (Others)
Wang HM, Huang YW, Huang JS et al (2007) Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma. Ann Surg Oncol 14:3011–3018 (Others)
Nakamura T, Yana I, Kobayashi T (1992) p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas. Jpn J Cancer Res 83:1293–1298 (Others)
Bond JA, Oddweig Ness G, Rowson J et al (1996) Spontaneous de-differentiation correlates with extended lifespan in transformed thyroid epithelial cells: an epigenetic mechanism of tumour progression? Int J Cancer 67:563–572 (Others)
Hunt JL, Tometsko M, LiVolsi VA et al (2003) Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. Am J Surg Pathol 27:1559–1564 (Others)
Aratake Y, Nomura H, Kotani T et al (2006) Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study. Am J Clin Pathol 125:399–406 (Others)
Wiseman SM, Masoudi H, Niblock P et al (2006) Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma. Am J Surg 191:581–587 (Others)
Wallin G, Bäckdahl M, Tallroth-Ekman E (1989) Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study. Eur J Surg Oncol 15:43–48 (RS)
Wiseman SM, Loree TR, Hicks WL Jr et al (2003) Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation by means of the inter-simple sequence repeat polymerase chain reaction. Arch Otolaryngol Head Neck Surg 129:96–100 (Others)
Rodrigues RF, Roque L, Rosa-Santos J (2004) Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas. Br J Cancer 90:492–496 (Others)
Salvatore G, Nappi TC, Salerno P et al (2007) A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. Cancer Res 67:10148–10158 (Others)
O’Neill JP, O’Neill B, Condron C et al (2005) Anaplastic (undifferentiated) thyroid cancer: improved insight and therapeutic strategy into a highly aggressive disease. J Laryngol Otol 119:585–591 (NR)
Thyroid Carcinoma Task Force (2001) AACE/AAES Medical/Surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 7:202–220 (Others)
Singer PA, Cooper DS, Daniels GH et al (1996) Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 156:2165–2172 (Others)
Sherman SI, Angelos P, Ball DW et al (2009) National comprehensive cancer network. Clinical practice guidelines in oncology-v.1. Thyroid carcinoma. http://www.nccn.org/(on line) (Others)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Japan
About this chapter
Cite this chapter
Sugino, K., Onoda, N. (2013). CQ39. Should Relapsed Lesions of Differentiated Carcinoma That Were Diagnosed as Anaplastic Carcinoma Be Treated as Anaplastic Carcinoma?. In: Takami, H., Ito, Y., Noguchi, H., Yoshida, A., Okamoto, T. (eds) Treatment of Thyroid Tumor. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54049-6_52
Download citation
DOI: https://doi.org/10.1007/978-4-431-54049-6_52
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54048-9
Online ISBN: 978-4-431-54049-6
eBook Packages: MedicineMedicine (R0)